Erste Asset Management Gmb H Acadia Pharmaceuticals Inc Transaction History

Erste Asset Management Gmb H

$7.79 Trillion
Q1 2025

A detailed history of Erste Asset Management Gmb H transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Erste Asset Management Gmb H holds 242,300 shares of ACAD stock, worth $5.36 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

242,300

Previous 242,300 -0.0%

Holding current value

$5.36 Million

Previous $4.11 Billion 0.71%

% of portfolio

0.05%

Previous 0.05%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$15.14 - $19.14 $3.67 Million - $4.64 Million	242,300 New	242,300 $3.8 Billion
Q1 2024 Nov 26, 2024	BUY	$17.79 - $30.86 $1.67 Million - $2.9 Million	94,000 Added 63.39%	242,300 $4.41 Billion
Q4 2023 Nov 26, 2024	BUY	$20.78 - $31.77 $326,246 - $498,789	15,700 Added 11.84%	148,300 $4.65 Billion
Q3 2023 Nov 26, 2024	BUY	$20.84 - $33.47 $875,280 - $1.41 Million	42,000 Added 46.36%	132,600 $2.85 Billion
Q3 2022 Nov 26, 2024	SELL	$14.11 - $18.27 $2.14 Million - $2.77 Million	-151,700 Reduced 62.61%	90,600 $1.46 Billion
Q2 2022 Nov 26, 2024	BUY	$13.01 - $27.22 $577,644 - $1.21 Million	44,400 Added 96.1%	90,600 $1.29 Billion
Q1 2022 Nov 22, 2024	SELL	$20.94 - $27.5 $228,246 - $299,750	-10,900 Reduced 10.74%	90,600 $2.21 Billion
Q4 2021 Nov 22, 2024	SELL	$16.79 - $27.09 $2.36 Million - $3.81 Million	-140,800 Reduced 58.11%	101,500 $2.43 Billion
Q4 2020 Nov 22, 2024	SELL	$41.04 - $56.79 $861,840 - $1.19 Million	-21,000 Reduced 17.14%	101,500 $5.46 Billion
Q3 2020 Nov 22, 2024	SELL	$36.42 - $57.0 $4.36 Million - $6.83 Million	-119,800 Reduced 49.44%	122,500 $4.95 Billion
Q2 2020 Nov 22, 2024	SELL	$39.26 - $52.73 $431,860 - $580,030	-11,000 Reduced 9.57%	104,000 $5.01 Billion
Q1 2020 Nov 22, 2024	BUY	$31.65 - $46.87 $1.83 Million - $2.71 Million	57,800 Added 101.05%	115,000 $4.75 Billion
Q4 2019 Nov 22, 2024	SELL	$36.21 - $51.4 $6.7 Million - $9.51 Million	-185,100 Reduced 76.39%	57,200 $2.52 Billion
Q1 2019 Nov 22, 2024	SELL	$16.17 - $27.38 $3.17 Million - $5.37 Million	-196,100 Reduced 80.93%	46,200 $1.23 Billion
Q4 2018 Nov 26, 2024	SELL	$14.32 - $22.92 $2.81 Million - $4.49 Million	-196,100 Reduced 80.93%	46,200 $714 Million

Others Institutions Holding ACAD

# of Institutions

351

Shares Held

165M

Call Options Held

1.77M

Put Options Held

307K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.58B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.

Account

Erste Asset Management Gmb H Acadia Pharmaceuticals Inc Transaction History